Cyclacel Pharmaceuticals
BGMS • NASDAQ • Stock Fundamentals
Cyclacel Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sing Ee Wong, with a market cap of $5.3M.
Market Cap$5.3M
Employees12.0
CEOSing Ee Wong
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Cyclacel Pharmaceuticals FAQ
Common questions about Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals (BGMS) has a market capitalization of $5.3M and trades on NASDAQ.
Cyclacel Pharmaceuticals has approximately 12 employees.